Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2008

01-11-2008 | Original Paper

Does Cyclophosphamide Play a Protective Role Against Neuronal Loss in Chronic T. cruzi Infection?

Authors: Leony Cristina Caetano, Sérgio Zucoloto, Laura Midori Kawasse, Miriam Paula Alonso Toldo, José Clóvis do Prado Jr.

Published in: Digestive Diseases and Sciences | Issue 11/2008

Login to get access

Abstract

In this study, we verified the possible role of cyclophosphamide (CY) in protecting or not against neuronal losses in young and aged male Calomys callosus chronically infected with the MORC-1 strain of Trypanosoma cruzi through numerical quantification of neurons from the myenteric plexus of the colon and quantification of nitric-oxide concentration (NO) during the acute and chronic phase of infection. For this purpose, groups of young C. callosus were infected with the MORC-1 strain of T. cruzi. A group of infected animals received i.p. 0.2 mg/ml genuxal dissolved in distilled water treatment with CY. NO concentration in aged animals displayed reduced levels when compared to those found in young animals. No significant alterations in the number of neurons were observed in young animals, but for aged ones, a protective role of CY in reducing neuron loss was noted, in addition to enhancing the neuronal volume, area, and perimeter. These results suggest that CY administration, depending on the dose and time span, can act as a protective agent against neuronal losses.
Literature
5.
6.
go back to reference Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL (2004) Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189:909–918. doi:10.1086/381682 PubMedCrossRef Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL (2004) Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189:909–918. doi:10.​1086/​381682 PubMedCrossRef
8.
go back to reference Prata A (2004) Clinical and epidemiological aspects of Chagas disease. Lancet 1:92–100 Prata A (2004) Clinical and epidemiological aspects of Chagas disease. Lancet 1:92–100
9.
go back to reference Köberle F (1968) Chagas’ disease and Chagas’ syndrome: the pathology of American trypanosomiasis. Adv Parasitol 6:63–116PubMedCrossRef Köberle F (1968) Chagas’ disease and Chagas’ syndrome: the pathology of American trypanosomiasis. Adv Parasitol 6:63–116PubMedCrossRef
10.
go back to reference Albuquerque S, Ribeiro RD, Carraro AA, Ruberval AL, Prado JC, Garcia ART, Toldo MP (1993) Infecção natural no morcego Myotis nigricans nigricans pelo Trypanosoma cruzi. In: 45 Reunião Annual. Universidade Federal de Pernambuco, Pernambuco, p4.G.1.3.767 Albuquerque S, Ribeiro RD, Carraro AA, Ruberval AL, Prado JC, Garcia ART, Toldo MP (1993) Infecção natural no morcego Myotis nigricans nigricans pelo Trypanosoma cruzi. In: 45 Reunião Annual. Universidade Federal de Pernambuco, Pernambuco, p4.G.1.3.767
11.
go back to reference Krishnan C, Drachman D, McArthur J (2006) High-dose cyclophosphamide in the treatment of aggressive multiple sclerosis. Neurology 66(Suppl. 2):A30 (abstract P01.072) Krishnan C, Drachman D, McArthur J (2006) High-dose cyclophosphamide in the treatment of aggressive multiple sclerosis. Neurology 66(Suppl. 2):A30 (abstract P01.072)
12.
go back to reference Brener Z (1962) Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4:389–396PubMed Brener Z (1962) Therapeutic activity and criterion of cure in mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4:389–396PubMed
16.
go back to reference Sala MA, Komeseu MC, Lopes RA, Maia Campos G (1994) Karyometry study of basal cell carcinoma. Braz Dent J 5:11–14PubMed Sala MA, Komeseu MC, Lopes RA, Maia Campos G (1994) Karyometry study of basal cell carcinoma. Braz Dent J 5:11–14PubMed
17.
go back to reference Killian JM, Bressler RB, Armstrong RM, Huston DP (1988) Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch Neurol 45:27–30PubMed Killian JM, Bressler RB, Armstrong RM, Huston DP (1988) Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis. Arch Neurol 45:27–30PubMed
18.
go back to reference Gobbini MI, Smith ME, Richert ND, Frank JA, McFarland HF (1999) Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis. J Neuroimmunol 99:142–149. doi:10.1016/S0165-5728(99)00039-9 PubMedCrossRef Gobbini MI, Smith ME, Richert ND, Frank JA, McFarland HF (1999) Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis. J Neuroimmunol 99:142–149. doi:10.​1016/​S0165-5728(99)00039-9 PubMedCrossRef
19.
go back to reference Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL (1999) Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease. Mult Scler 5:403–409PubMed Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL (1999) Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease. Mult Scler 5:403–409PubMed
22.
go back to reference Evans TG, Reed SS, Hibbis JR (1996) Nitric oxide production in murine leismaniasis: correlation of progressive infection with increase in systemic synthesis of nitric oxide. Am J Trop Méd Hyg 54:486–489PubMed Evans TG, Reed SS, Hibbis JR (1996) Nitric oxide production in murine leismaniasis: correlation of progressive infection with increase in systemic synthesis of nitric oxide. Am J Trop Méd Hyg 54:486–489PubMed
23.
go back to reference Adams LB, Hibbis JB, Taintor RR, Kraheenbuhl JL (1990) Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen from l-arginine. J Immunol 144:2725–2729PubMed Adams LB, Hibbis JB, Taintor RR, Kraheenbuhl JL (1990) Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen from l-arginine. J Immunol 144:2725–2729PubMed
24.
go back to reference Gazzinelli RT, Oswald IP, Hienry S, James SL, Sher A (1992) The microbicidal activity of interferon-γ-treated macrophages against T. cruzi involves and l-arginine-dependent, nitrogen oxide mediated mechanism inhibitable by IL-10 and transforming growth factor-β. Eur J Immunol 22:2501–2507. doi:10.1002/eji.1830221006 PubMedCrossRef Gazzinelli RT, Oswald IP, Hienry S, James SL, Sher A (1992) The microbicidal activity of interferon-γ-treated macrophages against T. cruzi involves and l-arginine-dependent, nitrogen oxide mediated mechanism inhibitable by IL-10 and transforming growth factor-β. Eur J Immunol 22:2501–2507. doi:10.​1002/​eji.​1830221006 PubMedCrossRef
25.
go back to reference Farrel AJ, Blake DR, Palmer MJ, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219–1222CrossRef Farrel AJ, Blake DR, Palmer MJ, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219–1222CrossRef
26.
go back to reference Garcia SB, Paula JS, Giovannetti GS, Zenha F, Ramalho EM, Zucoloto S, Silva JS, Cunha FQ (1999) Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol 93:191–197. doi:10.1006/expr.1999.4451 PubMedCrossRef Garcia SB, Paula JS, Giovannetti GS, Zenha F, Ramalho EM, Zucoloto S, Silva JS, Cunha FQ (1999) Nitric oxide is involved in the lesions of the peripheral autonomic neurons observed in the acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol 93:191–197. doi:10.​1006/​expr.​1999.​4451 PubMedCrossRef
28.
29.
go back to reference Andrade SG, Mesquita IMO, Jambeiro JF, Magalhães-Santos IF, Portella RS (2003) Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias. Rev Soc Brás Méd Trop 36:441–447PubMed Andrade SG, Mesquita IMO, Jambeiro JF, Magalhães-Santos IF, Portella RS (2003) Treatment with benznidazole in association with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi: investigation into the possible development of neoplasias. Rev Soc Brás Méd Trop 36:441–447PubMed
30.
go back to reference Alcântara FG (1964) Experimental Chagas’ disease (visceral manifestations). O Hospital 66:625–633PubMed Alcântara FG (1964) Experimental Chagas’ disease (visceral manifestations). O Hospital 66:625–633PubMed
31.
go back to reference Banhos CRA (1996) Estudo da área nucleolar e sua relação com a área nuclear, em megacólon de pacientes chagásicos. Rev Reg Ciênci 5:41–80 Banhos CRA (1996) Estudo da área nucleolar e sua relação com a área nuclear, em megacólon de pacientes chagásicos. Rev Reg Ciênci 5:41–80
32.
go back to reference Tafuri WL (1971) Light and electron microscope studies of the autonomic nervous system in experimental and human American trypanosomiasis. Virchows Arch 354:136–149. doi:10.1007/BF00548079 CrossRef Tafuri WL (1971) Light and electron microscope studies of the autonomic nervous system in experimental and human American trypanosomiasis. Virchows Arch 354:136–149. doi:10.​1007/​BF00548079 CrossRef
Metadata
Title
Does Cyclophosphamide Play a Protective Role Against Neuronal Loss in Chronic T. cruzi Infection?
Authors
Leony Cristina Caetano
Sérgio Zucoloto
Laura Midori Kawasse
Miriam Paula Alonso Toldo
José Clóvis do Prado Jr.
Publication date
01-11-2008
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0260-8

Other articles of this Issue 11/2008

Digestive Diseases and Sciences 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.